Literature DB >> 20206173

Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer.

Benjamin Schumacher1, Justine Mondry, Philipp Thiel, Michael Weyand, Christian Ottmann.   

Abstract

The adaptor protein 14-3-3 binds to and stabilizes the tumor suppressor p53 and enhances its anti-tumour activity. In the regulatory C-terminal domain of p53 several 14-3-3 binding motifs have been identified. Here, we report the crystal structure of the extreme C-terminus (residues 385-393, p53pT387) of p53 in complex with 14-3-3sigma at a resolution of 1.28A. p53pT387 is accommodated by 14-3-3 in a yet unrecognized fashion implying a rationale for 14-3-3 binding to the active p53 tetramer. The structure exhibits a potential binding site for small molecules that could stabilize the p53/14-3-3 protein complex suggesting the possibility for therapeutic intervention. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206173     DOI: 10.1016/j.febslet.2010.02.065

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

1.  Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15.

Authors:  Yukari Okamoto; Sojin Shikano
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

Review 2.  Protein binding specificity versus promiscuity.

Authors:  Gideon Schreiber; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2010-11-09       Impact factor: 6.809

3.  Structural Basis for the Interaction of a Human Small Heat Shock Protein with the 14-3-3 Universal Signaling Regulator.

Authors:  Nikolai N Sluchanko; Steven Beelen; Alexandra A Kulikova; Stephen D Weeks; Alfred A Antson; Nikolai B Gusev; Sergei V Strelkov
Journal:  Structure       Date:  2017-01-12       Impact factor: 5.006

4.  Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling.

Authors:  Manuela Molzan; Benjamin Schumacher; Corinna Ottmann; Angela Baljuls; Lisa Polzien; Michael Weyand; Philipp Thiel; Rolf Rose; Micheline Rose; Philipp Kuhenne; Markus Kaiser; Ulf R Rapp; Jürgen Kuhlmann; Christian Ottmann
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

Review 5.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

6.  Structural basis for recognition of H3T3ph and Smac/DIABLO N-terminal peptides by human Survivin.

Authors:  Jiamu Du; Alexander E Kelly; Hironori Funabiki; Dinshaw J Patel
Journal:  Structure       Date:  2012-01-11       Impact factor: 5.006

7.  Activation and control of p53 tetramerization in individual living cells.

Authors:  Giorgio Gaglia; Yinghua Guan; Jagesh V Shah; Galit Lahav
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-04       Impact factor: 11.205

Review 8.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

9.  Molecular tweezers modulate 14-3-3 protein-protein interactions.

Authors:  David Bier; Rolf Rose; Kenny Bravo-Rodriguez; Maria Bartel; Juan Manuel Ramirez-Anguita; Som Dutt; Constanze Wilch; Frank-Gerrit Klärner; Elsa Sanchez-Garcia; Thomas Schrader; Christian Ottmann
Journal:  Nat Chem       Date:  2013-02-17       Impact factor: 24.427

10.  Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis.

Authors:  Mercedes Zurita; Pedro C Lara; Rosario del Moral; Blanca Torres; José Luis Linares-Fernández; Sandra Ríos Arrabal; Joaquina Martínez-Galán; Francisco Javier Oliver; José Mariano Ruiz de Almodóvar
Journal:  BMC Cancer       Date:  2010-05-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.